Entero Therapeutics, Inc. (ENTO)
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-30
Fiscal PeriodQ3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016
Total Revenue595,000$898$
QoQ%
YoY%
Cost Of Revenue0$0$
Gross Profit595,000$898$
Gross Margin100.00%100.00%
Operating Expenses934,787$638,864$821,386$1,203,511$1,892,607$3,426,108$9,099,048$4,093,621$3,433,137$4,181,644$4,062,425$2,279,671$(4,389,530$)5,405,853$9,382,072$11,166,981$30,399,478$9,276,888$8,213,541$17,398,679$3,711,934$2,393,704$2,928,451$1,125,839$4,082,074$4,932,191$4,603,644$4,048,380$2,486,006$3,093,023$3,594,362$2,272,140$2,976,117$2,124,435$2,708,492$2,264,940$1,288,030$1,724,972$1,347,216$368,811$1,408,964$
Operating Income(934,787$)(638,864$)(821,386$)(1,203,511$)(1,892,607$)(3,426,108$)(9,099,048$)(4,093,621$)(3,433,137$)(4,181,644$)(4,062,425$)(2,279,671$)4,389,530$(5,405,853$)(9,382,072$)(11,166,981$)(30,399,478$)(9,276,888$)(8,213,541$)(17,398,679$)(3,711,934$)(2,393,704$)(2,928,451$)(1,125,839$)(4,082,074$)(4,932,191$)(4,603,644$)(4,018,380$)(2,566,006$)(3,263,023$)(3,584,362$)(2,302,140$)(2,726,117$)(2,384,435$)(2,808,492$)(1,064,940$)(2,188,030$)(1,724,972$)(1,347,216$)(368,811$)(1,408,964$)
Operating Margin(1,576.82%)(1,033,061.02%)
Interest Income0$0$200$229$218$228$224$229$205$1,873$4,686$2,664$926$139$403$
Interest Expenses36,069$36,067$0$0$0$66,202$7,048$1,250$5,178$8,987$6,193$863$3,218$5,605$2,395$742$2,954$5,144$2,197$1,203,404$2,302,174$2,332,839$155,784$110,398$110,646$57,111$1,428$5,629$46,154$48,635$178,872$408,106$287,347$874$4,110,876$724,867$388,063$713,680$644,861$520,551$
Income Before Tax(970,856$)(674,931$)(948,105$)(12,238,269$)(1,895,252$)(3,430,222$)(9,099,473$)(4,100,940$)(3,434,158$)(4,189,232$)(4,070,653$)(3,985,989$)4,391,331$(5,408,145$)(9,626,839$)(11,172,487$)(30,400,788$)(9,278,944$)(7,685,629$)(17,400,392$)(5,313,906$)(4,695,878$)(5,261,290$)(1,281,623$)(4,192,472$)(5,042,837$)(4,660,755$)(4,019,808$)(2,571,635$)(3,309,177$)(3,632,997$)(2,481,012$)(3,134,223$)(2,671,782$)(2,809,366$)(5,631,523$)(3,198,168$)(3,770,651$)(1,991,320$)(666,208$)(1,873,929$)
Tax Expenses0$4,255,247$(14,859,887$)0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
Net Income(1,152,809$)(998,271$)(1,259,620$)(12,238,269$)(2,580,971$)(8,807,702$)5,567,606$(4,100,940$)(3,434,158$)(4,189,232$)(4,070,653$)(3,985,989$)4,391,331$(5,408,145$)(9,626,839$)(11,172,487$)(30,400,788$)(9,278,944$)(7,685,629$)(17,400,392$)(5,313,906$)(4,695,878$)(5,261,290$)(1,281,623$)(4,192,472$)(5,042,837$)(4,660,755$)(4,019,808$)(2,571,635$)(3,309,177$)(3,632,997$)(2,481,012$)(3,134,223$)(2,671,782$)(2,809,366$)(5,631,523$)(3,198,168$)(3,770,651$)(1,991,320$)(666,208$)(1,873,929$)
Profit Margin(1,617.96%)(1,033,289.98%)
TTM
Earnings to Minority90,745$82,165$81,262$90,189$84,632$38,058$66,144$77,081$49,292$94,324$87,431$(2,068$)157,578$144,425$90,792$116,229$118,089$3,450,866$22,295,555$905,660$8,155,212$
Earnings to Common Shareholders(1,243,554$)(1,080,436$)(1,340,882$)(12,328,458$)(2,665,603$)(8,845,760$)5,501,462$(4,178,021$)(3,483,450$)(4,283,556$)(4,158,084$)(3,983,921$)4,233,753$(5,552,570$)(9,717,631$)(11,288,716$)(30,518,877$)(12,729,810$)(29,981,184$)(18,306,052$)(13,469,118$)(4,695,878$)(5,261,290$)(1,281,623$)(4,192,472$)(5,042,837$)(4,660,755$)(4,019,808$)(2,571,635$)(3,309,177$)(3,632,997$)(2,481,012$)(3,134,223$)(2,671,782$)(2,809,366$)(5,631,523$)(3,198,168$)(3,770,651$)(1,991,320$)(666,208$)(1,873,929$)
QoQ%(15.10%)19.42%89.12%(362.50%)69.87%(260.79%)231.68%(19.94%)18.68%(3.02%)(4.37%)(194.10%)176.25%42.86%13.92%63.01%(139.74%)57.54%(63.78%)(35.91%)(186.83%)10.75%(310.52%)69.43%16.86%(8.20%)(15.95%)(56.31%)22.29%8.91%(46.43%)20.84%(17.31%)4.90%50.11%(76.09%)15.18%(89.35%)(198.90%)64.45%
YoY%53.35%87.79%(124.37%)(195.08%)23.48%(106.51%)232.31%(4.87%)(182.28%)22.86%57.21%64.71%113.87%56.38%67.59%38.33%(126.58%)(171.09%)(469.85%)(1,328.35%)(221.27%)6.88%(12.89%)68.12%(63.03%)(52.39%)(28.29%)(62.02%)17.95%(23.86%)(29.32%)55.94%2.00%29.14%(41.08%)(745.31%)(70.67%)
Earnings Per Share, Basic(0.75$)(0.23$)(0.28$)(1.51$)(1.76$)(3.86$)3.12$(5.65$)(9.21$)(37.73$)(36.46$)15.15$18.51$(53.47$)(131.28$)0.84$(98.00$)(1.63$)(5.42$)0.39$(4.72$)(0.17$)(0.20$)0.02$(0.17$)(0.25$)(0.26$)0.09$(0.15$)(0.22$)(0.29$)(0.21$)(0.28$)(0.27$)(0.29$)(0.61$)(0.53$)(0.63$)(0.42$)(0.52$)
Earnings Per Share, Diluted(0.75$)(0.23$)2.69$(1.76$)(3.86$)0.38$(5.65$)(9.21$)(37.73$)(36.46$)14.95$18.23$(53.47$)(131.28$)0.84$(98.00$)(1.63$)(5.42$)0.39$(4.72$)(0.17$)(0.20$)0.02$(0.17$)(0.25$)(0.26$)0.09$(0.15$)(0.22$)(0.29$)(0.21$)(0.28$)(0.27$)(0.29$)(0.61$)(0.53$)(0.63$)(0.42$)(0.52$)
Unlevered FCF Per Share, Basic(0.52$)(0.01$)(0.17$)(0.02$)(1.22$)(1.50$)(2.13$)(4.65$)(8.81$)(24.32$)(24.95$)21.26$(18.60$)(44.16$)(106.89$)0.43$(50.51$)(0.72$)(0.92$)0.13$(0.95$)(0.05$)(0.05$)0.05$(0.17$)(0.20$)(0.15$)0.07$(0.16$)(0.17$)(0.18$)(0.21$)(0.12$)(0.22$)(0.12$)(0.22$)(0.11$)(0.13$)
Unlevered FCF Per Share, Diluted(0.52$)(0.01$)0.04$(1.22$)(1.50$)(0.26$)(4.65$)(8.81$)(24.32$)(24.95$)20.99$(18.32$)(44.16$)(106.89$)0.43$(50.51$)(0.72$)(0.92$)0.13$(0.95$)(0.05$)(0.05$)0.05$(0.17$)(0.20$)(0.15$)0.07$(0.16$)(0.17$)(0.18$)(0.21$)(0.12$)(0.22$)(0.12$)(0.22$)(0.11$)(0.13$)
Average Shares, Basic1,652,6794,765,0044,765,0048,166,2351,517,3402,294,2081,761,953739,488378,301113,546114,033-262,991228,773103,84474,022-13,488,652311,4117,812,4405,534,813-46,435,6482,851,88328,016,47826,941,803-63,162,50724,962,69120,479,91717,719,902-44,637,15816,889,51915,300,19712,447,43811,576,92311,242,61610,064,7139,631,0889,264,3716,028,9285,999,9784,725,8793,587,455
Average Shares, Diluted1,652,6794,765,004-4,583,2731,517,3402,294,20814,511,461739,488378,301113,546114,033-266,466232,248103,84474,022-13,488,652311,4117,812,4405,534,813-46,435,6482,851,88328,016,47826,941,803-63,162,50724,962,69120,479,91717,719,902-44,637,15816,889,51915,300,19712,447,43811,576,92311,242,61610,064,7139,631,0889,264,3716,028,9285,999,9784,725,8793,587,455
EBIT(934,787$)(638,864$)(948,105$)(12,238,269$)(1,895,252$)(3,430,222$)(9,033,271$)(4,093,892$)(3,432,908$)(4,184,054$)(4,061,666$)(3,979,796$)4,392,194$(5,404,927$)(9,621,234$)(11,170,092$)(30,400,046$)(9,275,990$)(7,680,485$)(17,398,195$)(4,110,502$)(2,393,704$)(2,928,451$)(1,125,839$)(4,082,074$)(4,932,191$)(4,603,644$)(4,018,380$)(2,566,006$)(3,263,023$)(3,584,362$)(2,302,140$)(2,726,117$)(2,384,435$)(2,808,492$)(1,520,647$)(2,473,301$)(3,382,588$)(1,277,640$)(21,347$)(1,353,378$)
EBITDA(934,787$)(638,864$)(948,105$)(12,238,269$)(1,893,916$)(3,394,905$)(9,020,978$)(4,086,573$)(3,425,590$)(4,176,735$)(4,054,348$)(3,972,796$)4,399,494$(5,397,627$)(9,613,934$)(11,164,092$)(30,394,046$)(9,273,990$)(7,679,485$)(17,398,195$)(4,110,502$)(2,393,704$)(2,928,451$)(1,125,839$)(4,082,074$)(4,932,191$)(4,603,644$)(4,018,380$)(2,566,006$)(3,263,023$)(3,584,362$)(2,302,140$)(2,726,117$)(2,384,435$)(2,808,492$)(1,520,647$)(2,473,301$)(3,382,588$)(1,277,640$)(21,347$)(1,353,378$)